A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy

Epilepsy Research
M ReunanenA W Yuen

Abstract

The efficacy and safety of lamotrigine and carbamazepine as monotherapy in patients with untreated, newly diagnosed or recurrent partial and/or generalised tonic-clonic seizures, were compared in a randomised, open, multicentre study. Patients received 24 weeks' treatment with oral lamotrigine 100 mg (LTG 100, n = 115) or 200 mg (LTG 200, n = 111) or carbamazepine 600 mg (CBZ 600, n = 117). Efficacy measurements were comparable between the three treatment groups, although the higher lamotrigine dose was possibly most effective, with 60.4% completing seizure free compared with 51.3% (LTG 100) and 54.7% (CBZ 600). Both dosage regimens of lamotrigine were well tolerated. More patients on CBZ 600 reported adverse experiences, 66% versus 53% (LTG 100) and 58% (LTG 200), and of these a greater proportion were attributed to CBZ 600 treatment, 53% versus 23% (LTG 100) and 28% (LTG 200). Similarly, a greater proportion of the CBZ 600 group required a change in dose, 47% versus 20% (LTG 100) and 17% (LTG 200) or withdrew completely due to adverse experiences, 10.3% versus 4.3% (LTG 100) and 4.5% (LTG 200). The most common adverse experience leading to withdrawal was rash, with approximately double the proportion of reports occurring in p...Continue Reading

Citations

Dec 7, 2000·Mental Retardation and Developmental Disabilities Research Reviews·J M Pellock, L D Morton
Dec 25, 2004·European Journal of Clinical Pharmacology·P D KnoesterY A Hekster
Mar 20, 2002·Current Neurology and Neuroscience Reports·Steven L Weinstein, Joan Conry
Oct 6, 2000·Pediatric Neurology·T F BarronM L Price
Nov 7, 1998·Pediatric Neurology·G BriassoulisT Hatzis
Jul 21, 2001·Epilepsy Research·M Nieto-BarreraUNKNOWN Lamictal vs. Carbamazepine Study Group
Nov 26, 2002·Epilepsy Research·Charles L P Deckers
Jan 11, 2002·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·H StefanO Steinlein
Aug 25, 2001·Epilepsia·E Perucca
Jun 26, 2003·Epilepsia·Antonio Gil-Nagel
Mar 13, 2002·European Journal of Pain : EJP·Emilio Perucca
Dec 28, 1999·Epilepsia·M V Lambert, M M Robertson
Oct 26, 1999·Epilepsia·F Matsuo
Feb 28, 2006·Epilepsia·Lawrence J HirschStanley R Resor
Oct 7, 2004·Postgraduate Medical Journal·S BeyenburgM Reuber
Nov 7, 2007·Trials·Catrin Tudur SmithPaula R Williamson
Mar 20, 2002·Pharmacotherapy·Thomas E Lackner
Mar 13, 2002·CNS Drugs·Charles L P Deckers
May 8, 2002·CNS Drugs·Meir BialerJosemir W Sander
Apr 17, 2003·CNS Drugs·Charles L P DeckersY A Hekster
Feb 20, 2002·British Journal of Clinical Pharmacology·John S Duncan
Jul 16, 2014·Immunology and Allergy Clinics of North America·Young-Min YeHae-Sim Park
Jun 8, 2013·Pharmacological Reports : PR·Barbara BłaszczykWładysław Lasoń
Mar 5, 2003·Acta Neurologica Scandinavica·M D PriviteraUNKNOWN EPMN 105 Study Group
Jun 17, 2006·Acta Neurologica Scandinavica. Supplementum·A AldenkampA Covanis
Dec 6, 2006·Expert Review of Neurotherapeutics·Sheetal MalikLawrence J Hirsch
Sep 27, 2003·Acta Neurologica Scandinavica. Supplementum·E Ben-MenachemS Stodieck
Mar 16, 2001·Expert Opinion on Pharmacotherapy·P H McCabe
Feb 4, 2003·Expert Opinion on Pharmacotherapy·Hyunmi Choi, Martha J Morrell
Jun 18, 2005·Seizure : the Journal of the British Epilepsy Association·Renzo GuerriniUNKNOWN TOP-INT-51 Investigators' Group
Apr 25, 2000·Seizure : the Journal of the British Epilepsy Association·J P Leach
Mar 1, 2012·Epilepsy & Behavior : E&B·Joyce A Cramer
May 30, 2007·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Pieter D KnoesterHans L Severens

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.